NR4A2 and major depressive disorder: In the MDD + SSRI group, we observed significant (p < 0.05) downregulation in the expression of ADM, and a trend for downregulation in EGR1 (p = 0.1) and NR4A2 (p = 0.1), as compared to the C group.